Development of Salvianolic Acid A‐Loaded Gelatin Nanoparticles for Effective Suppression of Inflammation and Oxidative Stress in Blood–Brain Barrier to Ischemic Stroke Therapy
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.2766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Chaoming Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Zhanjiang Second Traditional Chinese Medicine Hospital, Zhanjiang, China. Hauptthemen laut MEDLINE: Nanoparticles, Oxidative Stress, Blood-Brain Barrier, Gelatin. Die Arbeit nennt 62 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke (ICS) represents a treatment emergency for which efficient therapeutic options remain insufficient. Salvianolic acid A (SAA) is a naturally occurring polyphenol recognized as an effective neuroprotective agent. Compared with developed drugs, SAA demonstrates low side effects and displays several modes of action, providing considerable benefits in managing ICS. Yet, limitations of inadequate transmembrane permeability and water solubility hinder the effectiveness of SAA. Recently, nanodelivery methods have garnered significant attention in ICS as an efficient to penetrate the blood–brain barrier and enhance drug solubility. This investigation developed a new nanomedicine (SAA@GRH NPs) for ICS treatment, utilizing SAA‐loaded gelatin nanoparticles (SAA@GNPs) that were functionalized and altered with brain tissue target rabies virus glycoprotein (RVG29). The stability, antioxidant, antibacterial, neuroprotective effects, cellular uptake, and cytocompatibility of SAA@GRH NPs were examined. The in vivo efficacy of SAA@GRH NPs on ICS was studied in a rat model of middle cerebral artery occlusion (MCAO) with histological analysis. The resultant SAA@GRH NPs enhanced the solubility of SAA and demonstrated effective dispersion. In vitro studies indicate that SAA@GRH NPs possess significant antibacterial activities, antioxidant capabilities, and protection against intracellular reactive oxygen species. RVG29 markedly improved the absorption of SAA@GRH NPs by IMR32 cells. Moreover, in vivo investigations confirmed the efficacy of SAA@GRH NPs in mitigating nerve injury and facilitating neurological recovery. In the MCAO model, SAA@GRH NPs markedly diminished neuroinflammation, substantially recovered behavioral functions and decreased neuronal death. Collectively, our data suggested that SAA@GRH NPs may offer an innovative and promising strategy for the successful treatment of ICS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation, Zhanjiang Second Traditional Chinese Medicine Hospital, Zhanjiang, China.
- Department of Pulmonary Diseases, Zhanjiang Second Traditional Chinese Medicine Hospital, Zhanjiang, China.
- Department of Rehabilitation, the Fourth Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.
ORCID-Profile: Chaoming Li
Zitieren
APA
Li, C., Li, H., & Zhou, H. (2025). Development of Salvianolic Acid A‐Loaded Gelatin Nanoparticles for Effective Suppression of Inflammation and Oxidative Stress in Blood–Brain Barrier to Ischemic Stroke Therapy. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2766
Vancouver
Li C, Li H, Zhou H. Development of Salvianolic Acid A‐Loaded Gelatin Nanoparticles for Effective Suppression of Inflammation and Oxidative Stress in Blood–Brain Barrier to Ischemic Stroke Therapy. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2766
BibTeX
@article{Li2025,
author = {Li, Chaoming and Li, Haixin and Zhou, Haichun},
title = {Development of Salvianolic Acid A‐Loaded Gelatin Nanoparticles for Effective Suppression of Inflammation and Oxidative Stress in Blood–Brain Barrier to Ischemic Stroke Therapy},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.2766}
}
EUVIMED